Navigation Links
Prostratin- Drug to eradicate HIV

According to researchers at Peterson Medical College, a strategy was developed - using a natural compound to flush the Human Immunodeficiency Virus (HIV) out of dormancy in the cellular reservoirs of the body. Prostratin, an agent,comes from a Samoan rainforest tree, and appears to stimulate the virus, which causes AIDS, in a way that allows the body's immune system to detect and attack it.//

Dr. Roger Pomerantz, chief of the division of infectious diseases at Peterson Medical College feels that the action of that compund is two folded- Firstly it stops HIV from infecting other cells by decreasing receptors and it drives HIV out of latency. Though the therapy was only tested in a laboratory setting, the researchers predict they will gain approval to test their hypothesis in patients as early as next year.

Prostratin could be a crucial second tier treatment in the battle against HIV, the virus that causes AIDS. In the last five years, anti-HIV drugs, known as highly active antiretrovirus therapy (HAART), have brought the virus under control by drastically reducing its presence, or load, in patients. But HAART does not completely eradicate HIV. Instead, the virus goes into hiding and persists in undetectable levels in the blood. Prostratin therapy could provide a means by which to flag the furtive HIV in its hiding place. Then, by driving out the HIV, the HAART drugs and the body's own defenses can seek out and destroy it.

This may be the first drug that might stimulate both T-cells and macrophages, both of which might be reservoirs for virus. However this approach is debatable. Many researchers feel that the working of this compound is still to be confirmed and tested.

According to him it's an approach that, in the clinical community, there would be some level of resistance to. This is something that would turn the virus on and clinical prognosis is related to the levels of virus in the system. In fact, determining how mu ch of the virus needs to be "turned on" in order for the immune system and the HAART drugs to kill it, will be the most challenging part of developing prostratin for clinical use.

It's too soon to say that prostratin, for all its promising performance, will eradicate HIV-disease. When protease inhibitors were given to patients, researchers claimed that HIV will be 'eradicated'.


'"/>




Related medicine news :

1. Final push to eradicate leprosy
2. A way to eradicate allergy
3. Strategies by the State Government to eradicate Chikungunya
4. Polio can be eradicated in India: Health Experts
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/19/2017)... ... January 19, 2017 , ... WhoHaha , a digital ... the American Heart Association (AHA) to produce a three-part video series that uses humor ... as part of the launch of AHA’s Healthy For Good™ movement, which is designed ...
(Date:1/19/2017)... ... , ... Cosmetic Town, an online plastic surgery community, begins 2017 with an ... for their readers to get the information they desire. The procedures are now listed ... used on those particular areas. , “We are excited to streamline our listings in ...
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... ... technologies and development solutions for drugs, biologics and consumer health products, today announced ... Lipids,” with Gattefossé, the leader in innovative excipients and drug delivery solutions to ...
(Date:1/19/2017)... ... January 19, 2017 , ... MB ... a new $11,250,000 senior credit facility to Sunrise, Florida-based Management Health Systems, LLC, ... used to facilitate a recapitalization of MedPro led by Harren Equity Partners. ...
(Date:1/19/2017)... California (PRWEB) , ... January 19, 2017 , ... ... hands of a doctor who administered fillers that resulted in severe facial disfiguration. ... case was taken on by doctors at UCLA Medical Center, who removed the ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... ViewRay, Inc. (Nasdaq: VRAY) announced today that the German Research ... Germany , has purchased a MRIdian Linac ... Heidelberg as part of its initiative for MRI-based radiation ... headed by Medical Director and Professor Jürgen Debus, M.D., ... Cancer Research Center (DKFZ), the Heidelberg Heavy Ion Center ...
(Date:1/19/2017)... New Review of Safinamide ... Symptoms and Motor Complications in Mid- to Late-stage ... ... C Warren Olanow ... 2): 2-15, http://www.touchneurology.com/articles/safinamide-new-therapeutic-option-address-motor-symptoms-and-motor-complications-mid-late Published ...
(Date:1/19/2017)... CLEVELAND , Jan. 18, 2017  ViewRay, ... the world,s first and only clinical MRI-guided radiation ... gross proceeds of approximately $26.1 million through a ... Puissance Capital Management led the financing and was ... OrbiMed Advisors, LLC and Kearny Venture Partners, and ...
Breaking Medicine Technology: